Introductory Editorial — Critical Psychedelic Studies: Correcting the Hype
As we move past a phase of “partial eclipse” by psychedelic hype, this critical field is finally well-situated to explore the full spectrum of psychedelic effects.

It’s important that disability as a topic is easily identifiable in the scholarly record.
Including purified and isolated materials as eligible subject matter under 35 U.S.C. § 101 can benefit patients, researchers, and innovation.
Medical students spend a lot of time learning about conditions they will likely never treat. This has negative implications for patient care.
People who microdose psychedelics claim that it provides a very wide range of benefits. Is it just a placebo effect?
While standard doses of psychedelics will ostensibly be higher than a microdose, the question of just how much higher should be the topic of debate.
A mutual understanding of the term “microdosing psychedelics” is needed to conduct accurate research, promote regulations, and educate the wider population.